François Desjardins
Corporate Officer/Principal presso Ordre des comptables professionnels agréés du Québec
Profilo
François Desjardins is a Member of the Ordre des comptables professionnels agréés du Québec, and has previously worked as a Senior Vice President-Finance at BELLUS Health, Inc. from 2020 to 2022, and as a Controller at Biochem Pharma, Inc. from 1995 to 2001.
He is also a Member of The Canadian Institute of Chartered Accountants.
Mr. Desjardins obtained his undergraduate degree from the University of Sherbrooke in 1984.
Currently, he holds a position as a Member at the Ordre des comptables professionnels agréés du Québec.
Posizioni attive di François Desjardins
| Società | Posizione | Inizio |
|---|---|---|
Ordre des comptables professionnels agréés du Québec
 Ordre des comptables professionnels agréés du Québec Miscellaneous Commercial ServicesCommercial Services Ordre des comptables professionnels agréés du Québec provides financial services. It offers services related to assurance, financial & management accounting, and taxation. The company was founded in 2012 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - |
Precedenti posizioni note di François Desjardins
| Società | Posizione | Fine |
|---|---|---|
| BELLUS HEALTH | Director of Finance/CFO | 07/12/2020 |
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Comptroller/Controller/Auditor | 01/01/2001 |
The Canadian Institute of Chartered Accountants
 The Canadian Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Canadian Institute of Chartered Accountants engages in the provision of accounting, auditing, tax, advisory, and professional services. The institute is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Formazione di François Desjardins
| University of Sherbrooke | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
The Canadian Institute of Chartered Accountants
The Canadian Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Canadian Institute of Chartered Accountants engages in the provision of accounting, auditing, tax, advisory, and professional services. The institute is headquartered in Toronto, Canada. | Commercial Services |
Ordre des comptables professionnels agréés du Québec
Ordre des comptables professionnels agréés du Québec Miscellaneous Commercial ServicesCommercial Services Ordre des comptables professionnels agréés du Québec provides financial services. It offers services related to assurance, financial & management accounting, and taxation. The company was founded in 2012 and is headquartered in Montreal, Canada. | Commercial Services |
- Borsa valori
- Insiders
- François Desjardins
